Dual PPAR α/γ ligands have demonstrated potential in this context, as PPAR α activation improves hyperlipidemia by promoting beta-oxidation-related gene expression, while PPAR γ increases adipogenesis and fatty acid transport gene expression, leading to adipocyte accumulation (9). The gene discussed is PPARA; the disease is hyperlipidemia.